Immune predictors of cancer progression

How to develop better screens for anti-cancer therapies?

(2012) Michelle Hong et al.   OncoImmunology

Dacarbazine Promotes Stromal Remodeling and Lymphocyte Infiltration in Cutaneous Melanoma Lesions

(2011) Alessandra Nardin et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor

(2011) Benjamin Toh et al.   PLOS BIOLOGY

Myeloid-derived suppressor cell heterogeneity and subset definition

(2010) Elisa Peranzoni et al.   CURRENT OPINION IN IMMUNOLOGY

Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer

(2010) Julia H. Hayes et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma

(2010) Jo Eyles et al.   JOURNAL OF CLINICAL INVESTIGATION

Human Papillomavirus 16-Associated Cervical Intraepithelial Neoplasia in Humans Excludes CD8 T Cells from Dysplastic Epithelium

(2010) C. L. Trimble et al.   JOURNAL OF IMMUNOLOGY

Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer

(2009) S. Ostrand-Rosenberg et al.   JOURNAL OF IMMUNOLOGY

Screening, prevention and treatment of cervical cancer—A global and regional generalized cost-effectiveness analysis

(2009) Gary Michael Ginsberg et al.   VACCINE

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy

(2007) Ronald J Buckanovich et al.   NATURE MEDICINE